Back to search results

Playing Game to Learn About Children's Vaccine Project

This study is testing a special "vaccination game" to see if it helps young people learn about and consider getting the HPV (Human Papillomavirus) vaccine. We want to understand if this game can encourage more 11-14 year olds to get vaccinated, especially those who haven't received any doses yet. We're looking for about 180 participants who are 11-14 years old, speak and read English, and have never had the HPV vaccine. The study will measure how many people agree to join, how many stay in the study until the end, and how many complete the game and surveys. The study status is currently unclear.

Study design
This is an interventional study, meaning participants will receive a specific intervention (the vaccination game). It aims to enroll 180 participants and will compare the game-based intervention to usual care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for two months after completing the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05984849

Playing Game to Learn About Children's Vaccine Project

Recruiting
NAAges 11–14InterventionalPrevention
Michigan State University
~180 participants
Updated 2026-05-20 on ClinicalTrials.gov
What's tested:vaccination game

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of eligible individuals agreeing to participate
Measured over T0 (occurs after consenting and before assigning to different study conditions)
+4 more outcomes measured

Conditions

HPV
Vaccine-Preventable Diseases

Explore related trials

Human Papillomavirus Infection

Where it's being run

1 sites across 1 states
Arizona1

Study leadership

  • ANGELA C CHEN, PhD · PRINCIPAL_INVESTIGATOR · Michigan State University

Who to contact

ANGELA CHEN, PhD
[email protected]
(517) 884-4645
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Child sample: (1) 11-14 years old, (2) speaks and reads English, (3) has never received any doses of the HPV vaccine, (4) is not currently enrolled in another project that involves HPV-related education, and (5) agrees and provides assent to participate in research activities.
Parent sample: (1) parent or legal guardian of the participating child, (2) speak and read English, (3) own a smartphone, (4) agree to receive email and text messages, (5) is not currently enrolled in another project that involves HPV-related education, and (6) agree and provide consent to participate in research activities.

What this trial measures

  • Percentage of eligible individuals agreeing to participateT0 (occurs after consenting and before assigning to different study conditions)

    Assessed by the % of eligible individuals agreeing to participate

  • Proportion of participants who are retained through follow-upT2 (occurs two months after completion of the intervention)

    Assessed by the % of participants who are retained through follow-up

  • Percentage of participants who complete the intervention and assessmentsT2 (occurs two months after completion of the intervention)

    Assessed by the % of participants who complete the intervention and assessments

  • Participant satisfaction with the projectT2 (occurs two months after completion of the intervention)

    Assessed by two Likert scale questions: (1) are you satisfied with the program? (2) Will you recommend this program to others? Responses: from (1) very dissatisfied/definitely not to (5) very satisfied/definitely yes)

  • Intention to vaccinate the children against HPVT0 (occurs after consenting and before assigning to different study conditions); T1 (occurs immediately post intervention);T2 (occurs two months after completion of the intervention)

    Assessed by a Likert scale question: How likely will you (parent) vaccinate your child against HPV? Responses: (0) no; (1) maybe; (2) yes